DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/c8b8dp/proteinuria) has announced the addition of the "Proteinuria - Pipeline Review, H2 2013" report to their offering.

'Proteinuria - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Proteinuria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Proteinuria.

Scope

- A snapshot of the global therapeutic scenario for Proteinuria.

- A review of the Proteinuria products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Proteinuria pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

Introduction

Proteinuria Overview

Therapeutics Development

Pipeline Products for Proteinuria - Overview

Pipeline Products for Proteinuria - Comparative Analysis

Late Stage Products

Clinical Stage Products

Early Stage Products

Unknown Stage Products

Proteinuria - Products under Development by Companies

Proteinuria - Products under Investigation by Universities/Institutes

Proteinuria - Companies Involved in Therapeutics Development

Drug Profiles

paricalcitol - Drug Profile

FG-3019 - Drug Profile

losmapimod - Drug Profile

INV-141 - Drug Profile

pioglitazone hydrochloride - Drug Profile

corticotropin - Drug Profile

INV-142 - Drug Profile

Drug For Proteinuria - Drug Profile

voclosporin - Drug Profile

Featured News & Press Releases

Appendix

List of Tables

List of Figures

Companies Mentioned

Questcor Pharmaceuticals, Inc.

GlaxoSmithKline plc

FibroGen, Inc.

Dimerix Bioscience Pty Ltd

InVasc Therapeutics, Inc.

Aurinia Pharmaceuticals Inc.

For more information visit http://www.researchandmarkets.com/research/c8b8dp/proteinuria

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.